AUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Globus Medicalinc GMEDa leading musculoskeletal solutions company, announced today that its shareholders voted to issue Globus Medical Class A common stock in connection with its proposed merger with NuVasive at the extraordinary stockholders meeting held earlier today NUVA. As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Class A common stock in exchange for each NuVasive common share pending closing of the transaction.

“Globe Medical shareholders have overwhelmingly supported this merger,” said Dan Scavilla, Globus Medical President and CEO. “Globus Medical and NuVasive are committed to providing innovative technologies and industry-leading clinical support to help surgeons and healthcare providers continuously improve care. Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients. The combined company will have over 5,000 employees with a relentless focus on improving patients’ lives.”

Globus Medical Special Meeting Shareholder Vote Results:

• Class A Common Stock – 99.66% of the votes cast voted to approve the offering.
• Class B Common Stock – 100% voted to approve the offering.
• Overall, 99.92% of the votes cast voted in favor of the issue.
  

NuVasive separately announced that its shareholders voted to approve the company’s merger agreement with “strong support for NuVasive’s combination with Globus Medical” at its extraordinary shareholders’ meeting held earlier today.

The proposed merger is expected to close following regulatory approvals and the satisfaction of other customary closing conditions. At that time, NuVasive shareholders are expected to own approximately 28% of the combined company and Globus Medical shareholders…